<h4>Key clinical message</h4>Thrombotic microangiopathies are a side effect of anti-VEGF therapies, which are often limited to the kidneys but can also occur systemically and be life-threatening. The gene discussed is VEGFA; the disease is Genetic thrombotic microangiopathy.